Blended Mindfulness-Based Intervention for Persistent Depression

  • Research type

    Research Study

  • Full title

    Testing the Feasibility and Acceptability of a Blended Mindfulness-Based Intervention for Persistent Depression

  • IRAS ID

    284114

  • Contact name

    Jonathan Hamilton

  • Contact email

    jonathan.hamilton@surrey.ac.uk

  • Sponsor organisation

    University of Surrey

  • Clinicaltrials.gov Identifier

    NCT04576741

  • Duration of Study in the UK

    0 years, 5 months, 31 days

  • Research summary

    Depression is a major contributor to the burden of disease world-wide and poses a considerable challenge for treatment. About a third of those affected develop a course in which the disorder tends to become increasingly chronic or recurrent. Mindfulness-based interventions (MBIs) have been found to be particularly helpful in these cases. However, recent research suggests that the effectiveness of MBIs in depressed patients are contingent on sustained practice and standard group-based formats restrict accessibility.

    It is important, therefore, to find ways of supporting patients in their practice beyond the standard duration of MBIs. In order to address these challenges, we will test the feasibility and acceptability of a blended MBI program combining digital components (that is standard components such as educational content and guided meditations via an online platform) with online therapist contact via video conferencing, that supports patients in sustained practice.

    A sample of 24 patients with persistent depression will take part in the online programme over a period of three months, half of whom will be randomly allocated to engage in standard home practices and half of whom will receive the intervention with shorter home practices. Current symptoms, levels of stress and well-being will be assessed before, during and after the interventions. Experience sampling will be used to assess skills utilization. Qualitative interviews at the end of the intervention will serve to assess patients’ views on acceptability.

  • REC name

    London - Surrey Research Ethics Committee

  • REC reference

    20/LO/1096

  • Date of REC Opinion

    11 Dec 2020

  • REC opinion

    Further Information Favourable Opinion